Persistent Complete Remission on Long-Term Follow-Up after Early Lu-177 Psma Radioligand Therapy (IMAGE)

Society of Nuclear Medicine and Molecular Imaging

Persistent Complete Remission on Long-Term Follow-Up after Early Lu-177 Psma Radioligand Therapy

Caption

Lymph node and osseous metastatic, castration-resistant, and chemotherapy-naive prostate cancer (status post androgen-deprivation therapy using LHRH analogs and Bicalutamide) in a 62-year-old patient demonstrated no evidence of disease on Ga-68 PSMA PET/CT 8 months (center) and 17 months (right) after first PRLT.

Credit

HR Kulkarni et al., THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Germany

Usage Restrictions

Please use at least title and credit

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.